Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Champions Oncology Inc

CSBR ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Biotechnology & Medical Research ·

USA Micro Cap Analyst: N/A

Last Close

$5.07

▼ -0.30%

Market Cap $70.37M · Vol 3.61K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$70.37M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

26.95

Momentum

Beta

0.26

vs Market

52W High

$8.70

41.78% below

52W Low

$4.88

3.79% above

Volume

3.61K

Avg 3.13K

P/B

21.01

Price-to-book

ROE

N/A

Return on equity

Free Float

73.34%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Champions Oncology Inc (CSBR) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does CSBR pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-2.41%

-10.51%

-19.73%

-16.69%

YTD

-26.70%

-22.32%

-22.91%

-53.06%

Financials & Valuation

TTM · Annual

Total Revenue	$59.43M
Net Income	$-1,175,000.00
Revenue Growth (YoY)	+11.98%
Gross Margin	48.00%
Operating Margin	-1.73%
Net Profit Margin	-1.98%
ROE	N/A
ROA · ROIC	-3.13% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	1.39
P/B	21.01
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	13.89M

Technical Indicators

50-Day SMA	$5.86
200-Day SMA	$6.23
RSI (14)	26.95
Beta	0.26
52-Week High	$8.70
52-Week Low	$4.88

Volume Today	3.61K
Avg Daily Volume (30D)	3.13K
Relative Volume	1.15x
Volatility (10D)	51.64
Volatility (30D)	51.13
Free Float	73.34%

Analyst Consensus

N/A

Current Price $5.07

Mean Target N/A

52W Low$4.88 52W High$8.70

Current

Target

$4.88 $8.70

Current Analyst target

· 0 analysts

Identifiers

ExchangeNasdaq

FIGIBBG001S5YHT9

ISINUS15870P3073

CountryUnited States of America

Sub-IndustryBiotechnology & Medical Research (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LONN.S Lonza Group AG -1.78% RVMD Revolution Medicines Inc +0.85% ONC BeOne Medicines AG -2.40% 068270.KS Celltrion Inc -0.50% ABVX Abivax SA -2.05%

Company Profile

Champions Oncology, Inc. is a preclinical and clinical research services provider. The Company is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions (TOS). This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. It also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.